九大研究贯通两大板块:艾帕洛利托沃瑞利单抗以全病程布局回应消化道肿瘤之困

同花顺
Oct 27

编者按:2026年欧洲肿瘤内科学会(ESMO)年会于10月23日至27日在西班牙马德里召开,作为全球肿瘤领域最具影响力的学术盛会之一,ESMO始终聚焦前沿诊疗进展,引领临床实践变革方向。本届年会上,齐鲁制药携多项消化道肿瘤领域临床研究成果重磅亮相,PD-1/CTLA-4组合抗体艾帕洛利托沃瑞利单抗全面布局肝胆胰、胃肠食管两大消化道肿瘤板块,覆盖从新辅助、转化治疗到一线、后线的全治疗阶段,共计9项...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10